Literature DB >> 29310926

Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.

Ashok Sharma1, Xiang Liu2, David Hadley3, William Hagopian4, Wei-Min Chen5, Suna Onengut-Gumuscu5, Carina Törn6, Andrea K Steck7, Brigitte I Frohnert7, Marian Rewers7, Anette-G Ziegler8, Åke Lernmark6, Jorma Toppari9, Jeffrey P Krischer2, Beena Akolkar10, Stephen S Rich5, Jin-Xiong She11.   

Abstract

Traditional linkage analysis and genome-wide association studies have identified HLA and a number of non-HLA genes as genetic factors for islet autoimmunity (IA) and type 1 diabetes (T1D). However, the relative risk associated with previously identified non-HLA genes is usually very small as measured in cases/controls from mixed populations. Genetic associations for IA and T1D may be more accurately assessed in prospective cohorts. In this study, 5806 subjects from the TEDDY (The Environmental Determinants of Diabetes in the Young) study, an international prospective cohort study, were genotyped for 176,586 SNPs on the ImmunoChip. Cox proportional hazards analyses were performed to discover the SNPs associated with the risk for IA, T1D, or both. Three regions were associated with the risk of developing any persistent confirmed islet autoantibody: one known region near SH2B3 (HR = 1.35, p = 3.58 × 10-7) with Bonferroni-corrected significance and another known region near PTPN22 (HR = 1.46, p = 2.17 × 10-6) and one novel region near PPIL2 (HR = 2.47, p = 9.64 × 10-7) with suggestive evidence (p < 10-5). Two known regions (PTPN22: p = 2.25 × 10-6, INS; p = 1.32 × 10-7) and one novel region (PXK/PDHB: p = 8.99 × 10-6) were associated with the risk for multiple islet autoantibodies. First appearing islet autoantibodies differ with respect to association. Two regions (INS: p = 5.67 × 10-6 and TTC34/PRDM16: 6.45 × 10-6) were associated if the fist appearing autoantibody was IAA and one region (RBFOX1: p = 8.02 × 10-6) was associated if the first appearing autoantibody was GADA. The analysis of T1D identified one region already known to be associated with T1D (INS: p = 3.13 × 10-7) and three novel regions (RNASET2, PLEKHA1, and PPIL2; 5.42 × 10-6 > p > 2.31 × 10-6). These results suggest that a number of low frequency variants influence the risk of developing IA and/or T1D and these variants can be identified by large prospective cohort studies using a survival analysis approach.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune disorder; Gene mapping; Susceptibility; TEDDY study; Type 1 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29310926      PMCID: PMC5902429          DOI: 10.1016/j.jaut.2017.12.008

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   14.511


  59 in total

Review 1.  Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?

Authors:  Garth L Burn; Lena Svensson; Cristina Sanchez-Blanco; Manoj Saini; Andrew P Cope
Journal:  FEBS Lett       Date:  2011-04-20       Impact factor: 4.124

2.  Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.

Authors:  Ezio Bonifacio; Liping Yu; Alastair K Williams; George S Eisenbarth; Polly J Bingley; Santica M Marcovina; Kerstin Adler; Anette G Ziegler; Patricia W Mueller; Desmond A Schatz; Jeffrey P Krischer; Michael W Steffes; Beena Akolkar
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

3.  Neuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival.

Authors:  Jonàs Juan-Mateu; Tatiana H Rech; Olatz Villate; Esther Lizarraga-Mollinedo; Anna Wendt; Jean-Valery Turatsinze; Letícia A Brondani; Tarlliza R Nardelli; Tatiane C Nogueira; Jonathan L S Esguerra; Maria Inês Alvelos; Piero Marchetti; Lena Eliasson; Décio L Eizirik
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

4.  Polymorphisms of PXK are associated with autoantibody production, but not disease risk, of systemic lupus erythematosus in Chinese mainland population.

Authors:  B Yu; Q Wu; Y Chen; P Li; Y Shao; J Zhang; Q Zhong; X Peng; H Yang; X Hu; B Chen; M Guan; W Zhang; J Wan
Journal:  Lupus       Date:  2010-09-09       Impact factor: 2.911

5.  Common risk alleles for inflammatory diseases are targets of recent positive selection.

Authors:  Towfique Raj; Manik Kuchroo; Joseph M Replogle; Soumya Raychaudhuri; Barbara E Stranger; Philip L De Jager
Journal:  Am J Hum Genet       Date:  2013-03-21       Impact factor: 11.025

6.  The Erk2 MAPK regulates CD8 T cell proliferation and survival.

Authors:  Warren N D'Souza; Chiung-Fang Chang; April M Fischer; Manqing Li; Stephen M Hedrick
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

7.  Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers.

Authors:  Andrea K Steck; Fran Dong; Randall Wong; Alexandra Fouts; Edwin Liu; Jihane Romanos; Cisca Wijmenga; Jill M Norris; Marian J Rewers
Journal:  Pediatr Diabetes       Date:  2013-11-08       Impact factor: 4.866

8.  Emerging patterns of genetic overlap across autoimmune disorders.

Authors:  Corinne Richard-Miceli; Lindsey A Criswell
Journal:  Genome Med       Date:  2012-01-27       Impact factor: 11.117

9.  The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.

Authors:  William A Hagopian; Henry Erlich; Ake Lernmark; Marian Rewers; Anette G Ziegler; Olli Simell; Beena Akolkar; Robert Vogt; Alan Blair; Jorma Ilonen; Jeffrey Krischer; JinXiong She
Journal:  Pediatr Diabetes       Date:  2011-05-12       Impact factor: 3.409

10.  Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study.

Authors:  Jeffrey P Krischer; Kristian F Lynch; Åke Lernmark; William A Hagopian; Marian J Rewers; Jin-Xiong She; Jorma Toppari; Anette-G Ziegler; Beena Akolkar
Journal:  Diabetes Care       Date:  2017-06-23       Impact factor: 17.152

View more
  20 in total

1.  Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.

Authors:  Melis A Aksit; Rhonda G Pace; Briana Vecchio-Pagán; Hua Ling; Johanna M Rommens; Pierre-Yves Boelle; Loic Guillot; Karen S Raraigh; Elizabeth Pugh; Peng Zhang; Lisa J Strug; Mitch L Drumm; Michael R Knowles; Garry R Cutting; Harriet Corvol; Scott M Blackman
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 2.  The Genetic Contribution to Type 1 Diabetes.

Authors:  Marina Bakay; Rahul Pandey; Struan F A Grant; Hakon Hakonarson
Journal:  Curr Diab Rep       Date:  2019-11-04       Impact factor: 4.810

Review 3.  Endotypes in T1D: B lymphocytes and early onset.

Authors:  Mia J Smith; John C Cambier; Peter A Gottlieb
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-08       Impact factor: 3.243

4.  Maternal food consumption during late pregnancy and offspring risk of islet autoimmunity and type 1 diabetes.

Authors:  Randi K Johnson; Roy Tamura; Nicole Frank; Ulla Uusitalo; Jimin Yang; Sari Niinistö; Carin Andrén Aronsson; Anette-G Ziegler; William Hagopian; Marian Rewers; Jorma Toppari; Beena Akolkar; Jeffrey Krischer; Suvi M Virtanen; Jill M Norris
Journal:  Diabetologia       Date:  2021-03-30       Impact factor: 10.460

5.  Untangling the genetic link between type 1 and type 2 diabetes using functional genomics.

Authors:  Denis M Nyaga; Mark H Vickers; Craig Jefferies; Tayaza Fadason; Justin M O'Sullivan
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

Review 6.  The β Cell in Diabetes: Integrating Biomarkers With Functional Measures.

Authors:  Steven E Kahn; Yi-Chun Chen; Nathalie Esser; Austin J Taylor; Daniël H van Raalte; Sakeneh Zraika; C Bruce Verchere
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 25.261

7.  Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study.

Authors:  Jeffrey P Krischer; Xiang Liu; Åke Lernmark; William A Hagopian; Marian J Rewers; Jin-Xiong She; Jorma Toppari; Anette-G Ziegler; Beena Akolkar
Journal:  Diabetologia       Date:  2021-07-22       Impact factor: 10.460

8.  Time-Resolved Autoantibody Profiling Facilitates Stratification of Preclinical Type 1 Diabetes in Children.

Authors:  David Endesfelder; Wolfgang Zu Castell; Ezio Bonifacio; Marian Rewers; William A Hagopian; Jin-Xiong She; Åke Lernmark; Jorma Toppari; Kendra Vehik; Alistair J K Williams; Liping Yu; Beena Akolkar; Jeffrey P Krischer; Anette-G Ziegler; Peter Achenbach
Journal:  Diabetes       Date:  2018-10-10       Impact factor: 9.337

9.  A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.

Authors:  Jeremy T Warshauer; Julia A Belk; Alice Y Chan; Jiaxi Wang; Alexander R Gupta; Quanming Shi; Nikolaos Skartsis; Yani Peng; Jonah D Phipps; Dante Acenas; Jennifer A Smith; Stanley J Tamaki; Qizhi Tang; James M Gardner; Ansuman T Satpathy; Mark S Anderson
Journal:  J Exp Med       Date:  2021-06-11       Impact factor: 14.307

Review 10.  The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update.

Authors:  Marian Rewers; Heikki Hyöty; Åke Lernmark; William Hagopian; Jin-Xiong She; Desmond Schatz; Anette-G Ziegler; Jorma Toppari; Beena Akolkar; Jeffrey Krischer
Journal:  Curr Diab Rep       Date:  2018-10-23       Impact factor: 5.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.